Comment and reply on: Vasohibin-1 and its emerging role in the evolution and progression of systemic tumors besides renal cell carcinomas

Author： Kapoor Shailendra  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.1, 2013-01, pp. : 105-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment and reply on:Emerging role of Th22 and IL-22 in multiple sclerosis, an autoimmune disease in the central nervous system

By Zhou Chunkui   Zhang Beilin   Yang Yi   Zhang Hongliang  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1381-1382

Informa Healthcare

Access to resources Recommend Favorite

Reply to progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

By Becker Andreas   Eichelberg Christian   Sun Maxine  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1906-1907

Blackwell Publishing

Access to resources Recommend Favorite

MicroRNA-221 and its Rapidly Evolving Role in the Progression of Systemic Malignancies, Especially Gastrointestinal Malignancies

By Kapoor S  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 2029-2030

Field House Publishing

Access to resources Recommend Favorite

Emerging drugs for renal cell carcinoma

By Varella Leticia   Rini Brian I  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 343-353

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for renal cell carcinoma

By Shaheen Philip E   Bukowski Ronald M  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 773-795

Informa Healthcare

Access to resources Recommend Favorite